Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine

Generic Name: meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine (ma-nin-ja-KOK-al/hem-OFF-fill-us B)
Brand Name: Menhibrix

Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine is used for:

Preventing infection caused by certain types of bacteria (Neisseria meningitidis, Haemophilus influenzae) in children 6 weeks through 18 months old.

Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine is a vaccine combination. It works by causing the patient's immune system to produce antibodies against certain meningococcal bacteria and H. influenzae, which helps the patient's body to fight the infection.

Do NOT use meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine if:

  • the patient is allergic to any ingredient in meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine
  • the patient has had a severe allergic reaction (eg, rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue) to a prior tetanus toxoid-, H. influenzae type b-, or meningococcal-containing vaccination

Contact the patient's doctor or health care provider right away if any of these apply the patient.

Slideshow: 2013 Drug News Round-Up: Top 20 Stories

Before using meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine:

Some medical conditions may interact with meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine. Tell the patient's doctor or pharmacist if the patient has any medical conditions, especially if any of the following apply to the patient:

  • if the patient is taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
  • if the patient has allergies to medicines, foods, or other substances
  • if the patient has immune system problems (eg, weakened immune system), HIV infection, problems with the patient's spleen, or if the patient has recently had or will be having any other vaccines
  • if the patient has any infection or illness, or the patient is undergoing chemotherapy or radiation therapy
  • if the patient has a history of Guillain-Barré syndrome
  • if the patient has a bleeding problem (eg, hemophilia) or low blood platelets
  • if the patient is a premature infant
  • if the patient is taking anticoagulants (eg, warfarin)

Some MEDICINES MAY INTERACT with meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine. Tell the patient's health care provider if the patient is taking any other medicines, especially any of the following:

  • Medicines that suppress the immune system such as corticosteroids (eg, prednisone), cancer chemotherapy (eg, methotrexate), or cyclosporine because they may decrease meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine's effectiveness. Check with the patient's doctor or pharmacist if you are unsure if any of the patient's medicines suppress the immune system

This may not be a complete list of all interactions that may occur. Ask the patient's health care provider if meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine may interact with other medicines that the patient takes. Check with the patient's health care provider before the patient starts, stops, or changes the dose of any medicine.

How to use meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine:

Use meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine as directed by the patient's doctor. Check the label on the medicine for exact dosing instructions.

  • Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine is usually administered as an injection at the patient's doctor's office, hospital, or clinic. Ask the patient's doctor or pharmacist any questions that you may have about meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine.
  • Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine is a clear to colorless solution. Do not use meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine if it has been frozen, contains particles, is cloudy or discolored, or if the vial is cracked or damaged.
  • Keep this product, as well as syringes and needles, out of the reach of children and away from pets. Do not reuse needles, syringes, or other materials. Ask the patient's health care provider how to dispose of these materials after use. Follow all local rules for disposal.
  • If the patient misses a dose of meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine, contact the patient's doctor immediately.

Ask the patient's health care provider any questions you may have about how to use meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine.

Important safety information:

  • Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine may not work as well in patients who have immune system problems or are taking medicine that suppresses the immune system, such as corticosteroids (eg, prednisone). Tell the patient's doctor if the patient has any immune system problems or other illnesses.
  • Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine should not be used as a substitute for normal tetanus vaccinations. Discuss any questions or concerns with the patient's doctor.
  • If the patient has a fever or an infection, the patient's doctor may delay giving this vaccine.
  • It is important that the patient complete the vaccination series.
  • Make sure the patient's health care provider has a complete record of the patient's vaccinations and is aware of the patient's current health status.
  • Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine may interfere with urine H. influenzae testing within 1 to 2 weeks after it has been given. Be sure the patient's doctor and lab personnel know the patient has received meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine.
  • Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine is not approved for use in CHILDREN younger than 6 weeks old or in patients older than 18 months old; safety and effectiveness in these patients have not been confirmed.
  • PREGNANCY and BREAST-FEEDING: It is not known if meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine can cause harm to the fetus. It is not known if meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine is found in breast milk. Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine is not approved for use in patients older than 18 months old.

Possible side effects of meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Decreased appetite; drowsiness; irritability; mild fever; pain, redness, or swelling at the injection site.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); burning, numbness, or tingling; fainting; seizures; severe or persistent swelling of the injected arm or leg; slow or shallow breathing; uncontrolled movements of arms or legs; vision changes; weakness in the arms, legs, or facial muscles.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact the patient's health care provider. Call the patient's doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine:

Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine is usually handled and stored by a health care provider. If the patient is using meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine at home, store meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine as directed by the patient's pharmacist or health care provider.

General information:

  • If you have any questions about meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine, please talk with the patient's doctor, pharmacist, or other health care provider.
  • Meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine is to be used only by the patient for whom it is prescribed. Do not share it with other people.
  • If the patient's symptoms do not improve or if they become worse, check with the patient's doctor.
  • Check with the patient's pharmacist about how to dispose of unused medicine.

This information should not be used to decide whether or not to take meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine or any other medicine. Only your health care provider has the knowledge and training to decide which medicines are right for you. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine. This information is not specific medical advice and does not replace information you receive from your health care provider. You must talk with your healthcare provider for complete information about the risks and benefits of using meningococcal (c, y) and haemophilus b tetanus toxoid conjugate vaccine.

Issue Date: September 3, 2014
Database Edition 14.3.1.003
Copyright © 2014 Wolters Kluwer Health, Inc.

Disclaimer: This information should not be used to decide whether or not to take this medicine or any other medicine. Only your health care provider has the knowledge and training to decide which medicines are right for you. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this medicine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not specific medical advice and does not replace information you receive from your health care provider. You must talk with your healthcare provider for complete information about the risks and benefits of using this medicine.

Hide
(web4)
Close